Evidence map›Paper›PMID 40852450›Full record

ArticleChemical science2025

Measuring the efficiency of synthetic routes and transformations using vectors derived from similarity and complexity.

Samuel Genheden, Gareth P Howell

Abstract read
In one paragraph

Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cost Evidence Yields the Viability of Metal Oxides Synthesis Routes.ACS sustainable chemistry & engineering · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Samuel GenhedenMolecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg Pepparedsleden 1 SE-431 83 Mölndal Sweden.ORCID https://orcid.org/0000-0002-7624-7363
Gareth P HowellChemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca Macclesfield SK10 2NA UK gareth.howell@astrazeneca.com.ORCID https://orcid.org/0000-0003-2845-6459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the aim of providing new tools for the design and assessment of synthetic routes, we describe an approach that mimics human interpretation whilst being highly amenable to machine implementation. The representation of molecular structures as 2D-coordinates derived from molecular similarity and complexity allows individual transformations to be viewed as vectors (reactant to product) where the magnitude and direction of travel can be used to assess and quantify efficiency. Using a dataset comprising 640k literature syntheses and 2.4m reactions taken from six journals between 2000 and 2020, we show that vectors derived in this way follow logical patterns when grouped by reaction type. Similarly, complete synthetic routes can be visualised as sequences of head-to-tail vectors traversing the range between starting material and target, allowing the efficiency with which this range is covered to be quantified. Three applications of the methodology are demonstrated: a comparison of CASP performance between two versions of AiZynthFinder for generating synthetic routes to 100k ChEMBL targets, analysis of predicted routes to a specific target molecule and, finally, a perspective on how the efficiency of published synthetic routes has changed over the last two decades.

Identifiers

PMID40852450
PMCPMC12368604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.